Pneumagen Announces Appointment of John Beadle as Non-Executive Director
St Andrews-based biotech firm raises £3.8 million - Business Insider
Milken Institute's COVID-19 Treatment and Vaccine Tracker tracks the development of treatments and vaccines for COVID-19 at covid-19tracker.milkeninstitute.org #COVID19 #coronavirus #COVID19treatment #COVID19vaccine @MilkenInstitute @FirstPersonSF
Viruses | Free Full-Text | Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection | HTML
Pneumagen embarks on phase 2 proof of concept influenza study
Covid-19: Anti-coronavirus nasal spray, Neumifil, in works in UK - AS USA
Neumifil - Pneumagen
COVID-19 update: The race to therapeutic development - ScienceDirect
Fife firm's nasal spray could hold key to Covid-19 – Daily Business
Milken Institute's COVID-19 Treatment and Vaccine Tracker tracks the development of treatments and vaccines for COVID-19 at covid-19tracker.milkeninstitute.org #COVID19 #coronavirus #COVID19treatment #COVID19vaccine @MilkenInstitute @FirstPersonSF
Scottish coronavirus drug is being rushed into clinical trials after it treated disease in labs | Daily Mail Online
Milken Institute's COVID-19 Treatment and Vaccine Tracker tracks the development of treatments and vaccines for COVID-19 at covid-19tracker.milkeninstitute.org #COVID19 #coronavirus #COVID19treatment #COVID19vaccine @MilkenInstitute @FirstPersonSF
Scientists say coronavirus could be treated by nasal spray that protects lungs - Mirror Online
Experimental Coronavirus Drug Neumifil Shows Promise in Lab, Scientists Hope to 'Rapidly' Start Clinical Trials
Pneumagen (@PneumagenLtd) / Twitter
Pneumagen (@PneumagenLtd) / Twitter
Beiruting - Life Style Blog - Covid-19: Anti-coronavirus nasal spray, Neumifil
Frazer Hall on LinkedIn: #inizio #iniziomedical #changemakers
Review of Therapies for COVID-19 and Consolidated Clinical Trial Results
Biotech Pneumagen raises £3.8m for nasal spray treatment for respiratory viruses - European Pharmaceutical Manufacturer
Biotech Pneumagen raises £3.8m for nasal spray treatment for respiratory viruses - European Pharmaceutical Manufacturer
Pneumagen doses first subject in Phase II influenza antiviral trial
Coronavirus: How to cut your hair at home amid Covid-19 lockdown - AS USA
Viruses | Free Full-Text | Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection | HTML
Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection
